“An Unrelenting Disaster Zone”: Merck’s Alzheimer’s Drug Fails in Phase III - BioLegacy Research

“An Unrelenting Disaster Zone”: Merck’s Alzheimer’s Drug Fails in Phase III

Post author:Sam
Post published:February 13, 2018
Post category:BioPharma

Alzheimer’s drug development took another hit.
Source: BioSpace